Association of CYP2C19*17/*17 Genotype With the Risk of Voriconazole- Associated Squamous Cell Carcinoma

被引：12
|
作者：
Williams, Kiyanna [1 ]
Arron, Sarah T. [2 ]
机构：
[1] Univ Calif San Francisco, Sch Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Dermatol, 1701 Divisadero St,3rd Floor, San Francisco, CA 94115 USA
来源：
JAMA DERMATOLOGY | 2016年 / 152卷 / 06期
关键词：
TRANSPLANT RECIPIENTS; ANTIFUNGAL AGENT; CYP2C19;
D O I：
10.1001/jamadermatol.2016.0351
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：719 / 720
页数：2
相关论文
共 50 条
  • [31] Influence of CYP2C19*2/*17 genotype on adverse drug reactions of voriconazole in patients after allo-HSCT: a four-case report
    Sienkiewicz, Beata
    Urbaniak-Kujda, Donata
    Dybko, Jaroslaw
    Wrobel, Tomasz
    Wiela-Hojenska, Anna
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (06) : 1103 - 1106
  • [32] Evaluation of CYP2C19 Genotype-Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell Transplant
    Patel, Jai N.
    Hamadeh, Issam S.
    Robinson, Myra
    Shahid, Zainab
    Symanowski, James
    Steuerwald, Nury
    Hamilton, Alicia
    Reese, Emily S.
    Plesca, Dragos C.
    Arnall, Justin
    Taylor, Margaret
    Trivedi, Jigar
    Grunwald, Michael R.
    Gerber, Jonathan
    Ghosh, Nilanjan
    Avalos, Belinda
    Copelan, Edward
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (03) : 571 - 579
  • [33] Voriconazole in a Pediatric CYP2C19 Rapid Metabolizer
    Lee, M.
    Sudbury, B.
    Plesa, A.
    Zorzi, A.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2024, 77 (02):
  • [34] Voriconazole toxicity related to polymorphisms in CYP2C19
    Suan, D.
    O'Connor, K.
    Booth, D. R.
    Liddle, C.
    Stewart, G. J.
    INTERNAL MEDICINE JOURNAL, 2011, 41 (04) : 364 - 365
  • [35] Association between CYP2C19 genotype and proguanil oxidative polymorphism
    Coller, JK
    Somogyi, AA
    Bochner, F
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 43 (06) : 659 - 660
  • [36] Frequency of the CYP2C19*17 polymorphism in a Chilean population and its effect on voriconazole plasma concentration in immunocompromised children
    N. Espinoza
    J. Galdames
    D. Navea
    M. J. Farfán
    C. Salas
    Scientific Reports, 9
  • [37] Modulation of CYP2C19 activity and genotype in patients with hepatic carcinoma
    Kurata, N
    Nishimura, Y
    Iwase, M
    Yasuhara, H
    DRUG METABOLISM REVIEWS, 2004, 36 : 112 - 112
  • [38] Correlation of CYP2C19 genotype with plasma voriconazole levels: a preliminary retrospective study in Indians
    Prerna K. Chawla
    Shweta R. Nanday
    Alpa J. Dherai
    Rajeev Soman
    Rohan V. Lokhande
    Prasad R. Naik
    Tester F. Ashavaid
    International Journal of Clinical Pharmacy, 2015, 37 : 925 - 930
  • [39] Frequency of the CYP2C19*17 polymorphism in a Chilean population and its effect on voriconazole plasma concentration in immunocompromised children
    Espinoza, N.
    Galdames, J.
    Navea, D.
    Farfan, M. J.
    Salas, C.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [40] Correlation of CYP2C19 genotype with plasma voriconazole levels: a preliminary retrospective study in Indians
    Chawla, Prerna K.
    Nanday, Shweta R.
    Dherai, Alpa J.
    Soman, Rajeev
    Lokhande, Rohan V.
    Naik, Prasad R.
    Ashavaid, Tester F.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (05) : 925 - 930
12345